Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Med Biotech Laboratories is a Uganda-based health research company/laboratory in Kampala focused on infectious diseases, particularly malaria and neglected tropical diseases. Publicly available evidence links the organization to Gates Foundation-funded work on maternal immunization strategies intended to protect infants against malaria and to diagnostic sample-preservation tools for soil-transmitted helminth infections. The group has also been involved in malaria vaccine research in collaboration with external academic and research partners, including work associated with the BK-SE36/CpG malaria vaccine in Uganda. Med Biotech Laboratories appears to operate primarily as a research-driven biotech organization rather than a commercial-stage pharmaceutical company, and limited public information is available on its corporate structure, financing, and commercial products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Med Biotech Laboratories.